Institutional Manager · CIK 0001595851
Ghost Tree Capital, LLC
NEW YORK, NY · File #028-16059
Latest AUM
$331.0M
Positions
54
Top-10 Concentration
43.0%
Filings
4
Portfolio Value Over Time
2023-12
2024-03
2024-06
2024-09
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| NEW | SPDR SER TR | 78464A870 | +300,000 | +$29.6M | $0 |
| NEW | BIOHAVEN LTD | G1110E907 | +348,778 | +$17.4M | $0 |
| EXITED | BIOHAVEN LTD | G1110E107 | -490,000 | -$17.0M | $0 |
| EXITED | ALNYLAM PHARMACEUTICALS INC | 02043Q107 | -68,400 | -$16.6M | $0 |
| NEW | NOVO-NORDISK A S | 670100205 | +110,000 | +$13.1M | $0 |
| REDUCE | VIRIDIAN THERAPEUTICS INC | 92790C104 | -512,708 | -$11.7M | +$5.7M |
| REDUCE | INSMED INC | 457669307 | -150,000 | -$10.9M | +$1.2M |
| ADD | BLUEPRINT MEDICINES CORP | 09627Y109 | +100,000 | +$9.3M | -$611,200 |
| REDUCE | MOONLAKE IMMUNOTHERAPEUTICS | 61559X104 | -171,589 | -$8.7M | +$1.9M |
| ADD | SAREPTA THERAPEUTICS INC | 803607100 | +65,000 | +$8.1M | -$1.8M |
Filing History
- 13F HOLDINGS REPORTQ/E Sep 202454 pos · $331.0M
- 13F HOLDINGS REPORTQ/E Jun 202463 pos · $319.3M
- 13F HOLDINGS REPORTQ/E Mar 202472 pos · $361.3M
- 13F HOLDINGS REPORTQ/E Dec 202370 pos · $304.1M
Top 20 Holdings — Sep 2024
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | SPDR SER TR | 78464A870 | 300,000 | $29.6M | 9.09% |
| 2 | BIOHAVEN LTD | G1110E907 | 348,778 | $17.4M | 5.34% |
| 3 | SAREPTA THERAPEUTICS INC | 803607100 | 120,000 | $15.0M | 4.59% |
| 4 | NOVO-NORDISK A S | 670100205 | 110,000 | $13.1M | 4.02% |
| 5 | BLUEPRINT MEDICINES CORP | 09627Y109 | 140,000 | $12.9M | 3.97% |
| 6 | AXSOME THERAPEUTICS INC | 05464T104 | 135,000 | $12.1M | 3.72% |
| 7 | TARSUS PHARMACEUTICALS INC | 87650L103 | 350,000 | $11.5M | 3.53% |
| 8 | PERSPECTIVE THERAPEUTICS INC | 46489V302 | 750,000 | $10.0M | 3.07% |
| 9 | CG ONCOLOGY INC | 156944100 | 250,000 | $9.4M | 2.89% |
| 10 | ROIVANT SCIENCES LTD | G76279101 | 800,000 | $9.2M | 2.83% |
| 11 | VAXCYTE INC | 92243G108 | 80,000 | $9.1M | 2.80% |
| 12 | VIKING THERAPEUTICS INC | 92686J106 | 140,000 | $8.9M | 2.72% |
| 13 | SYNDAX PHARMACEUTICALS INC | 87164F105 | 450,000 | $8.7M | 2.66% |
| 14 | JANUX THERAPEUTICS INC | 47103J105 | 190,000 | $8.6M | 2.65% |
| 15 | ASCENDIS PHARMA A/S | 04351P101 | 52,500 | $7.8M | 2.40% |
| 16 | CRINETICS PHARMACEUTICALS IN | 22663K107 | 150,000 | $7.7M | 2.35% |
| 17 | SOLENO THERAPEUTICS INC | 834203309 | 150,000 | $7.6M | 2.32% |
| 18 | TG THERAPEUTICS INC | 88322Q108 | 310,000 | $7.3M | 2.22% |
| 19 | REZOLUTE INC | 76200L309 | 1,474,995 | $7.2M | 2.19% |
| 20 | PHATHOM PHARMACEUTICALS INC | 71722W107 | 375,000 | $6.8M | 2.08% |